Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 5, 2025 • 7:00 PM ET

Date/Time Source News Release
03/17/2025 08:00 AM EDT GlobeNewswire atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
03/11/2025 07:00 AM EDT GlobeNewswire atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression
03/05/2025 07:00 AM EST GlobeNewswire atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression
02/24/2025 04:10 PM EST GlobeNewswire atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
02/20/2025 07:00 AM EST GlobeNewswire atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
02/12/2025 10:47 PM EST GlobeNewswire atai Life Sciences Announces Pricing of Public Offering of Common Shares
02/12/2025 04:01 PM EST GlobeNewswire atai Life Sciences Announces Proposed Public Offering of Common Shares
01/28/2025 07:00 AM EST GlobeNewswire atai Life Sciences Announces Positive Topline Results from Beckley Psytech's BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder
01/10/2025 07:00 AM EST GlobeNewswire atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health
11/13/2024 08:00 AM EST GlobeNewswire atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Page

Additional News

As of April 5, 2025 • 7:00 PM ET

Date/Time Source News Release
03/19/2025 11:05 AM EDT InvestorBrandNetwork DOD to Invest $9.8m into Psychedelic Studies Targeting Active-Duty Soldiers
03/18/2025 05:31 AM EDT US Earnings Reports Expected earnings - ATAI Life Sciences N.V.
03/17/2025 08:10 AM EDT SeekingAlpha ATAI Life Sciences GAAP EPS of -$0.24 misses by $0.10
03/05/2025 10:05 AM EST InvestorBrandNetwork Study Finds That Bad Psychedelic Trips Double Some Individuals' Fatality Risk
03/03/2025 10:42 AM EST SeekingAlpha Germany's DAX Index are up +25% in the last six months, reaching an all-time high
02/27/2025 12:45 PM EST SeekingAlpha Atai: Following The Path That Spravato Laid And Moving Beyond It
02/27/2025 07:35 AM EST Zacks LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
02/26/2025 08:05 AM EST Zacks Option Care (OPCH) Q4 Earnings and Revenues Surpass Estimates
02/25/2025 03:13 PM EST SeekingAlpha German equities are up despite country's turbulent economy in 2023, 2024
02/13/2025 09:28 AM EST SeekingAlpha atai Life Sciences prices $55M underwritten offering; shares down
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.